story of the week
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Recurrent Clostridium difficile Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection
Gastroenterology 2019 Jan 02;[EPub Ahead of Print], CL Hvas, SMD Jørgensen, SP Jørgensen, M Storgaard, L Lemming, MM Hansen, C Erikstrup, JF DahlerupFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.